|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
21
|
|
pubmed:dateCreated |
2005-11-9
|
|
pubmed:abstractText |
The use of erythropoietin in head and neck squamous cell carcinoma (HNSCC) has been associated with poor survival. This study examines the protein and mRNA expression of erythropoietin and erythropoietin receptor in HNSCC and their relation to hypoxia, hemoglobin (Hb), and clinical outcome.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/CA9 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Carbonic Anhydrases,
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Complementary,
http://linkedlifedata.com/resource/pubmed/chemical/Erythropoietin,
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobins,
http://linkedlifedata.com/resource/pubmed/chemical/RNA,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Erythropoietin
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
7614-20
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16278379-Anemia,
pubmed-meshheading:16278379-Anoxia,
pubmed-meshheading:16278379-Antigens, Neoplasm,
pubmed-meshheading:16278379-Carbonic Anhydrases,
pubmed-meshheading:16278379-Carcinoma, Squamous Cell,
pubmed-meshheading:16278379-Cytoplasm,
pubmed-meshheading:16278379-DNA, Complementary,
pubmed-meshheading:16278379-Disease-Free Survival,
pubmed-meshheading:16278379-Erythropoietin,
pubmed-meshheading:16278379-Female,
pubmed-meshheading:16278379-Follow-Up Studies,
pubmed-meshheading:16278379-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:16278379-Head and Neck Neoplasms,
pubmed-meshheading:16278379-Hemoglobins,
pubmed-meshheading:16278379-Humans,
pubmed-meshheading:16278379-Immunohistochemistry,
pubmed-meshheading:16278379-Male,
pubmed-meshheading:16278379-Protein Array Analysis,
pubmed-meshheading:16278379-RNA,
pubmed-meshheading:16278379-RNA, Messenger,
pubmed-meshheading:16278379-Receptors, Erythropoietin,
pubmed-meshheading:16278379-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:16278379-Transcription, Genetic,
pubmed-meshheading:16278379-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Relation of erythropoietin and erythropoietin receptor expression to hypoxia and anemia in head and neck squamous cell carcinoma.
|
|
pubmed:affiliation |
Cancer Research UK Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, University of Oxford.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
